Wen-Juan Yu Selected Research

Therapeutics

2/2020

Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen-Juan Yu Research Topics

Disease

4	Neoplasms (Cancer) 01/2020 - 07/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2022 - 01/2016
3	Leukemia 01/2020 - 10/2007
2	Infections 08/2022 - 07/2019
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 12/2016
1	Fever (Fevers) 08/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021
1	Multi-centric Castleman's Disease 02/2020
1	Renal Insufficiency (Renal Failure) 02/2020
1	Disease Progression 02/2020
1	Hyperglycemia 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Diabetes Mellitus 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Perivascular Epithelioid Cell Neoplasms 01/2020
1	Philadelphia Chromosome 01/2020
1	Residual Neoplasm 12/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Hemangioma (Angioma) 01/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2014
1	Squamous Cell Carcinoma of Head and Neck 07/2013
1	Parkinson Disease (Parkinson's Disease) 07/2013
1	Epilepsy (Aura) 02/2012
1	Seizures (Absence Seizure) 02/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2012
1	Diabetes Complications 01/2012
1	Invasive Fungal Infections 07/2011
1	Hematologic Neoplasms (Hematological Malignancy) 07/2011
1	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2011
1	Hypoxia (Hypoxemia) 05/2010
1	Plasmacytoma 06/2009
1	Jaundice (Icterus) 06/2009
1	Brain Ischemia (Cerebral Ischemia) 04/2009
1	Reperfusion Injury 04/2009

Drug/Important Bio-Agent (IBA)

2	Decitabine FDA Link 08/2022 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2019
1	venetoclaxIBA 08/2022
1	Azacitidine (5 Azacytidine)FDA Link 08/2022
1	Hemoglobins (Hemoglobin)IBA 08/2022
1	Lenalidomide (CC 5013)FDA Link 02/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 01/2020
1	AsparagineIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 07/2019
1	Messenger RNA (mRNA)IBA 07/2019
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	Keratins (Keratin)IBA 01/2015
1	thiazolyl blueIBA 03/2014
1	KinesinsIBA 03/2014
1	Small Interfering RNA (siRNA)IBA 03/2014
1	BromidesIBA 07/2013
1	Fluorouracil (Carac)FDA LinkGeneric 07/2013
1	alpha-SynucleinIBA 07/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2012
1	Pentylenetetrazole (Metrazol)IBA 02/2012
1	GABA-A Receptor AntagonistsIBA 02/2012
1	Aminobutyrates (Aminobutyric Acid)IBA 02/2012
1	NAD (NADH)IBA 01/2012
1	Voriconazole (Vfend)FDA LinkGeneric 07/2011
1	Oxygen (Dioxygen)IBA 06/2011
1	Nerve Growth Factors (Neurotrophins)IBA 05/2010
1	Bortezomib (Velcade)FDA Link 06/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2009
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2009
1	erucylphosphocholineIBA 04/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009
1	tanespimycin (17AAG)IBA 10/2007
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2007

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2021 - 06/2009
2	Nephrectomy 01/2015 - 01/2015
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Therapeutics 02/2020
1	Renal Dialysis (Hemodialysis) 02/2020
1	Induction Chemotherapy 12/2016
1	Aftercare (After-Treatment) 12/2016
1	Electroacupuncture 04/2009